在 COVID-19 大流行期间提供癌症护理。
Provision of cancer care during the COVID-19 pandemic.
机构信息
School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Guy's & St Thomas' NHS Foundation Trust, London, UK.
出版信息
Nat Rev Clin Oncol. 2020 Jun;17(6):329-331. doi: 10.1038/s41571-020-0370-6.
Abstract
Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.
摘要
医疗保健服务正在迅速调整其组织和劳动力，以应对 2019 年冠状病毒病（COVID-19）大流行。这些变化以及减轻感染风险的愿望，对护理的其他重要方面产生了深远的影响，包括癌症患者的护理。尽管有限的证据表明癌症是感染和死亡的独立危险因素，但仍在做出关于积极治疗和姑息治疗的优先级的艰难决策。
相似文献
1
Provision of cancer care during the COVID-19 pandemic.在 COVID-19 大流行期间提供癌症护理。
Nat Rev Clin Oncol. 2020 Jun;17(6):329-331. doi: 10.1038/s41571-020-0370-6.
2
Palliative Care for Patients With Cancer in the COVID-19 Era.新冠疫情时代癌症患者的姑息治疗
JAMA Oncol. 2020 Oct 1;6(10):1527-1528. doi: 10.1001/jamaoncol.2020.1938.
3
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.在 COVID-19 大流行期间治疗癌症患者的实用考虑因素。
JCO Oncol Pract. 2020 Aug;16(8):467-482. doi: 10.1200/OP.20.00229. Epub 2020 May 13.
4
Cancer and COVID-19: how understanding grief helps the pandemic frontlines.癌症与新冠疫情：理解悲痛如何助力抗疫前线
Curr Oncol. 2020 Aug;27(4):e440-e441. doi: 10.3747/co.27.6777. Epub 2020 Aug 1.
5
Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic.放射肿瘤学诊所中 SARS-CoV-2 表面污染的流行情况。
JAMA Oncol. 2020 Oct 1;6(10):1632-1634. doi: 10.1001/jamaoncol.2020.3552.
6
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.癌症患者出现 COVID-19 症状，无论 RT-PCR 是否检测到 SARS-COV-2，死亡率均较高。
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
7
Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.癌症患者合并SARS-CoV-2感染的发热性中性粒细胞减少症的管理
JCO Oncol Pract. 2020 Jun;16(6):348-349. doi: 10.1200/OP.20.00197. Epub 2020 May 5.
8
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
9
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
10
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.2019冠状病毒病（COVID-19）与免疫参与性癌症治疗
JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.
引用本文的文献
1
The impact of the COVID-19 pandemic on the small cell lung cancer epidemiology.2019年冠状病毒病大流行对小细胞肺癌流行病学的影响。
Discov Oncol. 2025 Jun 9;16(1):1037. doi: 10.1007/s12672-025-02816-5.
2
Rapid mutation detection in extracellular vesicle DNA.细胞外囊泡DNA中的快速突变检测
Extracell Vesicles Circ Nucl Acids. 2025 Feb 17;6(1):72-86. doi: 10.20517/evcna.2024.69. eCollection 2025.
3
Research Priorities of the Oncology Nursing Society: 2024-2027.肿瘤护理学会研究重点：2024-2027 年。
Oncol Nurs Forum. 2024 Oct 17;51(6):502-515. doi: 10.1188/24.ONF.502-515.
4
Management and outcomes of breast cancer patients with radiotherapy interruption.放疗中断的乳腺癌患者的管理与结局
Front Oncol. 2024 Jul 23;14:1337194. doi: 10.3389/fonc.2024.1337194. eCollection 2024.
5
Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review.新冠疫情对英国和爱尔兰的乳腺癌患者诊疗路径和结局的影响：一项范围综述。
Br J Cancer. 2024 Sep;131(4):619-626. doi: 10.1038/s41416-024-02703-w. Epub 2024 May 4.
6
Rapid mutation detection in extracellular vesicle-DNA.细胞外囊泡DNA中的快速突变检测
bioRxiv. 2024 Feb 29:2024.02.26.582068. doi: 10.1101/2024.02.26.582068.
7
COVID-19 and Cancer: Questions to Be Answered.新冠病毒与癌症：待解答的问题
J Hosp Palliat Care. 2021 Mar 1;24(1):66-68. doi: 10.14475/jhpc.2021.24.1.66.
8
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).在英国（UKCCP）的一项基于人群的时间病例对照评估中，研究了癌症患者中 COVID-19 疾病表型和相关结局发生率。
Sci Rep. 2023 Jul 25;13(1):11327. doi: 10.1038/s41598-023-36990-9.
9
A Hybrid Algorithm of ML and XAI to Prevent Breast Cancer: A Strategy to Support Decision Making.一种用于预防乳腺癌的机器学习与可解释人工智能混合算法：一种支持决策的策略
Cancers (Basel). 2023 Apr 25;15(9):2443. doi: 10.3390/cancers15092443.
10
Revitalising cancer trials post-pandemic: time for reform.后疫情时代重振癌症临床试验：是时候进行改革了。
Br J Cancer. 2023 Apr;128(8):1409-1414. doi: 10.1038/s41416-023-02224-y. Epub 2023 Mar 23.
本文引用的文献
1
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.免疫抑制与刺激药物和新型冠状病毒肺炎之间的关联——当前证据的系统评价
Ecancermedicalscience. 2020 Mar 27;14:1022. doi: 10.3332/ecancer.2020.1022. eCollection 2020.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.癌症、COVID-19 和预防原则：在全球大流行期间优先考虑治疗。
Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
6
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
7
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
Zotero 插件